Avalyn Pharma Closes $175M Series C Financing
Avalyn Pharma Inc., a Seattle, WA-based clinical-stage biopharmaceutical company focused on development of targeted inhalation therapies for life-threatening pulmonary diseases, closed a $175m Series C financing. The round was co-led